mirtazapine has been researched along with Delayed Effects, Prenatal Exposure in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smit, M | 1 |
| Dolman, KM | 1 |
| Honig, A | 1 |
| Lennestål, R | 1 |
| Källén, B | 1 |
1 review available for mirtazapine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Mirtazapine in pregnancy and lactation - A systematic review.
Topics: Antidepressive Agents, Tricyclic; Breast Feeding; Depressive Disorder; Female; Humans; Lactation; Mi | 2016 |
1 other study available for mirtazapine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Age | 2007 |